Azilect Parkinson

Parkinson's is everywhere in the world. Exact overall figures are not always available, even though an estimated four million people worldwide have the condition. Parkinson's disease belongs to a group of conditions called movement disorders. Parkinson's disease affects 1 to 1 January / 2 million people in the United States. The disorder occurs in all races but is somewhat more common among Caucasians. People with the disease may have difficulty walking, talking or doing simple tasks. Dysfunctional antioxidant mechanisms associated with age as well, suggesting that the acceleration of age-related changes in the production of dopamine may be a factor. Parkinson's disease patients have at least one parent with Parkinson's disease symptoms, suggesting a genetic factor may be involved. There is no cure for Parkinson's disease at present, drugs are used to try to control the symptoms of Parkinson's disease. The most widely used treatment is L-dopa in various forms. L-dopa is converted to dopamine in dopaminergic neurons by acid decarboxylase Aromatic L-amino (often known by its former name of dopa-decarboxylase). The most widely practiced treatment for speech disorders associated with Parkinson's disease is Lee Silverman Voice Treatment (LSVT). LSVT aims to increase voice volume. Regular exercise and / or therapy may be beneficial for the patient to maintain and improve mobility, flexibility, balance and range of motion. Nutrients have been used in clinical studies and are widely used by people with Parkinson's disease in order to partially treat PD or slow its deterioration.

The causes of Parkinson's Disease

Common causes and risk factors for Parkinson's Disease

The free radicals.

aging.

environmental toxins.

Genetic factors.

Trauma.

carbon monoxide poisoning.

Hydrocephalus.

Signs and symptoms of Parkinson's Disease

Disease signs and symptoms common to Parkinson

Depression and other emotional disorders.

Difficulty swallowing.

To chew and speak.

Urinary problems.

Constipation.

Skin problems.

sleep disorders.

Trembling of the hands, jaw, arms, legs and face.

Treatment of Parkinson's Disease

The common treatment of Parkinson's Disease

Successful treatment of Parkinson's disease involves much more than the consumption of drugs. Levodopa and carbidopa combination (Sinemet) is the cornerstone of treatment of Parkinson's.

Tolcapone inhibits the COMT enzyme, thereby prolonging the effects of L-dopa, and has been used to complement the L-dopa.

The most widely practiced treatment for speech disorders associated with Parkinson's disease is Lee Silverman Voice Treatment (LSVT).

Nutrients have been used in clinical studies and are widely used by people with Parkinson's disease in order to partially treat PD or slow its deterioration.

Catechol O-methyltransferase (COMT) inhibitors Act catabolism of dopamine inhibition, thus extending the half ring of L-dopa-life.

The surgical treatment of PD is generally considered for patients who respond to medication.

Azilect was approved for use as initial monotherapy in early Parkinson's disease. Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease.

Physical therapy can help strengthen and tone the muscles under-used, and give a better range of motion muscle rigidity.